Considering that the occurrence and development of neurological diseases, such as Alzheimer's disease and Parkinson's syndrome are related to cerebrovascular abnormalities 29, we expect that the AAV-BR1-CRISPR system will be widely used for dissecting the vascular mechanisms underlying neurological diseases. This evidence concerns the gene CXCL11 and early-onset autosomal dominant Alzheimer disease.